Forbes: Patent Reform Should Not Bail Out Big Drug Companies
There is little debate that patent law is a complicated subject, yet the idea of protecting intellectual and private property is a centerpiece of American free market capitalism. Congress is once again contemplating changes to patent law to help consumers by cracking down on costly and abusive patent lawsuits. Seeing an opportunity, lobbyists for big drug companies are trying to attach a proposal that would do the opposite – harm consumers, American competitiveness and is a special interest provision that is tantamount to cronyism. Read More >>
